Moexipril Hydrochloride
4 NDCs across 2 manufacturers|4 Generic,0 Brand
Moexipril Hydrochloride is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 19, 1995, and the first generic was approved May 8, 2003. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient.
Moexipril Hydrochloride is available as 4 NDCs from 2 manufacturers (4 generic, 0 brand), with NADAC prices from $0.89 to $1.01 per EA — a 13% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
4G / 0B
Manufacturers
2
competing in market
Price Spread
$0.89 – $1.01
per EA
7d Activity
avg +0.5% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing MOEXIPRIL HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MOEXIPRIL HCL 15 MG TABLET | $1.0064 per EA | +0.43% |
MOEXIPRIL HCL 15 MG TABLET | $1.0064 per EA | +0.43% |
MOEXIPRIL HCL 7.5 MG TABLET | $0.8940 per EA | +0.50% |
MOEXIPRIL HCL 7.5 MG TABLET | $0.8940 per EA | +0.50% |
Frequently Asked Questions
What is Moexipril Hydrochloride used to treat?
Moexipril Hydrochloride is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Moexipril Hydrochloride become available as a generic?
FDA approved the first generic Moexipril Hydrochloride (ANDA) on May 8, 2003. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Moexipril Hydrochloride products are on the market?
The Moexipril Hydrochloride drug market contains 4 NDCs from 2 manufacturers — 4 generic and 0 brand products.
What is the price range for Moexipril Hydrochloride?
NADAC reference prices for Moexipril Hydrochloride range from $0.8940 to $1.0064 per EA — a 13% difference between cheapest and most expensive.
Which manufacturers make Moexipril Hydrochloride?
2 manufacturers list Moexipril Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (2), Glenmark Pharmaceuticals Inc., USA (2).
How has the price of Moexipril Hydrochloride changed recently?
Over the past 7 days, 4 Moexipril Hydrochloride NDCs rose and 0 fell, with a market-wide average change of +0.5%.